GW 9662 Partially Inhibits 15d-PGJ2-Mediated pp42/44 Activation

Medical University of Graz
Department of Cardiology
Postdoctoral Researcher

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Tocris Bioscience

Product Name:

GW 9662

Catalog Number:

1508/10

HL-1 cardiomyocytes were incubated with GW 9662 (2 µM) for 30 min prior to addition of 15 µM 15d-PGJ2 for 30 min. Preincubation of cells with GW 9662 partially abolished activation of p42/44 MAPK, while Tesaglitazar and T 0070907 inhibited the activation completely.

Experimental Design and Results Summary

Application

Cell culture

Starting Material

N/A

Protocol Overview

HL-1 cardiomyocytes were incubated with GW 9662 (2 µM) for 30 min prior to addition of 15 µM 15d-PGJ2 for 30 min.

Tips

N/A

Results Summary

Preincubation of cells with GW 9662 partially abolished activation of p42/44 MAPK, while Tesaglitazar and T 0070907 inhibited the activation completely.

DOI or PMID #

N/A

Additional Notes

N/A

Image Gallery

Summary

The Good

Some inhibition of pp42/44 activation

The Bad

Only partial inhibition

The Bottom Line

GW 9662 partially inhibits 15d-PGJ2-mediated pp42/44 activation.

Join the discussion